1. Academic Validation
  2. Chordin-Like 1 mRNA Therapy for Acute Myocardial Infarction

Chordin-Like 1 mRNA Therapy for Acute Myocardial Infarction

  • Circulation. 2025 Dec 2;152(22):1586-1589. doi: 10.1161/CIRCULATIONAHA.125.074078.
Mateusz Tomczyk 1 Izabela Kraszewska # 1 Gang Li # 1 Matthew John Hayes 2 Luca Venditti 1 Josef Huntington 1 Chun Kit Wong 1 Angelica Cadoni 1 Francesca Bortolotti 3 4 Antonio Mura 3 4 Manendra Pachauri 3 4 Gianfranco Sinagra 5 Mauro Giacca 3 4
Affiliations

Affiliations

  • 1 School of Cardiovascular and Metabolic Medicine and Sciences and BHF Centre for Research Excellence and Medical Research Council/British Heart Foundation Centre of Research Excellence in Advanced Cardiac Therapies, King's College London, London, United Kingdom (M.T., I.K., G.L., L.V., J.H., C.K.W., A.C.).
  • 2 Institute of Ophthalmology, University College London, London, United Kingdom (M.J.H.).
  • 3 Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy (F.B., A.M., M.P., M.G.).
  • 4 Molecular Medicine Laboratory, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy (F.B., A.M., M.P., M.G.).
  • 5 Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy (G.S.).
  • # Contributed equally.
Keywords

acute myocardial infarction; chordin-like 1 mRNA; lipid nanoparticle; myocardial infarction.

Figures
Products